Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Kidney Transplantation

  Free Subscription


Articles published in Kidney Int

Retrieve available abstracts of 44 articles:
HTML format
Text format



Single Articles


    December 2018
  1. KOPP JB
    Expanding the spectrum of APOL1-related renal disease: de novo collapsing glomerulopathy following kidney transplant.
    Kidney Int. 2018;94:1048-1050.
    PubMed     Text format     Abstract available


    November 2018
  2. JOHNSON SC, Martinez F, Bitto A, Gonzalez B, et al
    mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases.
    Kidney Int. 2018 Nov 21. pii: S0085-2538(18)30645.
    PubMed     Text format     Abstract available


  3. YAZDANI S, Callemeyn J, Gazut S, Lerut E, et al
    Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation.
    Kidney Int. 2018 Nov 2. pii: S0085-2538(18)30630.
    PubMed     Text format     Abstract available


    September 2018
  4. CASPER J, Schmitz J, Brasen JH, Khalifa A, et al
    Renal transplant recipients receiving loop diuretic therapy have increased urinary tract infection rate and altered medullary macrophage polarization marker expression.
    Kidney Int. 2018 Sep 22. pii: S0085-2538(18)30516.
    PubMed     Text format     Abstract available


    August 2018
  5. FRANCIS A, Johnson DW, Craig J, Teixeira-Pinto A, et al
    Post-transplant lymphoproliferative disease may be an adverse risk factor for patient survival but not graft loss in kidney transplant recipients.
    Kidney Int. 2018 Aug 26. pii: S0085-2538(18)30446.
    PubMed     Text format     Abstract available


    July 2018
  6. COEMANS M, Susal C, Dohler B, Anglicheau D, et al
    Analyses of the short- and long-term graft survival after kidney transplantation in Europe between 1986 and 2015.
    Kidney Int. 2018 Jul 20. pii: S0085-2538(18)30392.
    PubMed     Text format     Abstract available


    June 2018
  7. LANDWEHR-KENZEL S, Zobel A, Hoffmann H, Landwehr N, et al
    Ex vivo expanded natural regulatory T cells from patients with end-stage renal disease or kidney transplantation are useful for autologous cell therapy.
    Kidney Int. 2018;93:1452-1464.
    PubMed     Text format     Abstract available


    May 2018
  8. KOPP JB
    Global glomerulosclerosis in primary nephrotic syndrome: including age as a variable to predict renal outcomes.
    Kidney Int. 2018;93:1043-1044.
    PubMed     Text format     Abstract available


    April 2018
  9. TANER T, Gustafson MP, Hansen MJ, Park WD, et al
    Donor-specific hypo-responsiveness occurs in simultaneous liver-kidney transplant recipients after the first year.
    Kidney Int. 2018 Apr 12. pii: S0085-2538(18)30135.
    PubMed     Text format     Abstract available


    March 2018
  10. GREENLEAF E, Farooq U, Jain A, DiCristina R, et al
    Native kidney pyelonephritis as the cause of recurrent urinary tract infections in a kidney transplant recipient.
    Kidney Int. 2018;93:762.
    PubMed     Text format    


    February 2018
  11. DURAND M, Dubois F, Dejou C, Durand E, et al
    Increased degradation of ATP is driven by memory regulatory T cells in kidney transplantation tolerance.
    Kidney Int. 2018 Feb 15. pii: S0085-2538(18)30001.
    PubMed     Text format     Abstract available


  12. REICH B, Viehmann SF, Kurts C
    Plasmacytoid dendritic cells: important players in human kidney allograft rejection.
    Kidney Int. 2018;93:301-303.
    PubMed     Text format     Abstract available


    January 2018
  13. CHUTE DF, Chung RT, Sise ME
    Direct-acting antiviral therapy for hepatitis C virus infection in the kidney transplant recipient.
    Kidney Int. 2018 Jan 9. pii: S0085-2538(17)30807.
    PubMed     Text format     Abstract available


    December 2017
  14. LI J, Basler M, Alvarez G, Brunner T, et al
    Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation.
    Kidney Int. 2017 Dec 4. pii: S0085-2538(17)30773.
    PubMed     Text format     Abstract available


    October 2017
  15. LIM WH, Wong G, Heidt S, Claas FHJ, et al
    Novel aspects of epitope matching and practical application in kidney transplantation.
    Kidney Int. 2017 Oct 20. pii: S0085-2538(17)30604.
    PubMed     Text format     Abstract available


    September 2017
  16. YACOUB R, Nadkarni GN, Cravedi P, He JC, et al
    Analysis of OPTN/UNOS registry suggests the number of HLA matches and not mismatches is a stronger independent predictor of kidney transplant survival.
    Kidney Int. 2017 Sep 28. pii: S0085-2538(17)30547.
    PubMed     Text format     Abstract available


  17. PEARL MH, Zhang Q, Palma Diaz MF, Grotts J, et al
    Angiotensin II Type 1 receptor antibodies are associated with inflammatory cytokines and poor clinical outcomes in pediatric kidney transplantation.
    Kidney Int. 2017 Sep 16. pii: S0085-2538(17)30509.
    PubMed     Text format     Abstract available


  18. MENGEL M
    Deconstructing interstitial fibrosis and tubular atrophy: a step toward precision medicine in renal transplantation.
    Kidney Int. 2017;92:553-555.
    PubMed     Text format     Abstract available


    August 2017
  19. DE FIJTER JW
    Recurrence of glomerulonephritis: an underestimated and unmet medical need.
    Kidney Int. 2017;92:294-296.
    PubMed     Text format     Abstract available


    July 2017
  20. BROCKLEBANK V, Johnson S, Sheerin TP, Marks SD, et al
    Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland.
    Kidney Int. 2017 Jul 24. pii: S0085-2538(17)30323.
    PubMed     Text format     Abstract available


  21. KENTRUP D, Bovenkamp P, Busch A, Schuette-Nuetgen K, et al
    GlucoCEST magnetic resonance imaging in vivo may be diagnostic of acute renal allograft rejection.
    Kidney Int. 2017 Jul 11. pii: S0085-2538(17)30303.
    PubMed     Text format     Abstract available


    June 2017
  22. ALLEN PJ, Chadban SJ, Craig JC, Lim WH, et al
    Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomes.
    Kidney Int. 2017 Jun 7. pii: S0085-2538(17)30208.
    PubMed     Text format     Abstract available


  23. CLAYTON PA, Coates PT
    Are sensitized patients better off with a desensitization transplant or waiting on dialysis?
    Kidney Int. 2017;91:1266-1268.
    PubMed     Text format     Abstract available


    May 2017
  24. HAAS M
    Simultaneous liver-kidney transplantation: shifting renal allograft gene expression from inflammation toward preservation.
    Kidney Int. 2017;91:1010-1013.
    PubMed     Text format     Abstract available


  25. MJOEN G, Holdaas H
    Regarding "Obesity increases the risk of end-stage renal disease among living kidney donors".
    Kidney Int. 2017;91:1256.
    PubMed     Text format    


    April 2017
  26. GILL J, Rose C, Joffres Y, Kadatz M, et al
    Cold ischemia time up to 16 hours has little impact on living donor kidney transplant outcomes in the era of kidney paired donation.
    Kidney Int. 2017 Apr 19. pii: S0085-2538(17)30105.
    PubMed     Text format     Abstract available


  27. SCHAUERTE C, Hubner A, Rong S, Wang S, et al
    Antagonism of profibrotic microRNA-21 improves outcome of murine chronic renal allograft dysfunction.
    Kidney Int. 2017 Apr 8. pii: S0085-2538(17)30117.
    PubMed     Text format     Abstract available


  28. NADKARNI GN, Wyatt CM, Murphy B, Ross MJ, et al
    APOL1: a case in point for replacing race with genetics.
    Kidney Int. 2017;91:768-770.
    PubMed     Text format     Abstract available


  29. WIJKSTROM M, Iwase H, Paris W, Hara H, et al
    Renal xenotransplantation: experimental progress and clinical prospects.
    Kidney Int. 2017;91:790-796.
    PubMed     Text format     Abstract available


    March 2017
  30. LAM NN, Tonelli M, Lentine KL, Hemmelgarn B, et al
    Albuminuria and posttransplant chronic kidney disease stage predict transplant outcomes.
    Kidney Int. 2017 Mar 30. pii: S0085-2538(17)30093.
    PubMed     Text format     Abstract available


  31. BRASEN JH, Khalifa A, Schmitz J, Dai W, et al
    Macrophage density in early surveillance biopsies predicts future renal transplant function.
    Kidney Int. 2017 Mar 27. pii: S0085-2538(17)30094.
    PubMed     Text format     Abstract available


  32. SICARD A, Meas-Yedid V, Rabeyrin M, Koenig A, et al
    Computer-assisted topological analysis of renal allograft inflammation adds to risk evaluation at diagnosis of humoral rejection.
    Kidney Int. 2017 Mar 15. pii: S0085-2538(17)30038.
    PubMed     Text format     Abstract available


  33. RAVINDRAN A, Go RS, Fervenza FC, Sethi S, et al
    Thrombotic microangiopathy associated with monoclonal gammopathy.
    Kidney Int. 2017;91:691-698.
    PubMed     Text format     Abstract available


    February 2017
  34. SHIU KY, McLaughlin L, Rebollo-Mesa I, Zhao J, et al
    Graft dysfunction in chronic antibody-mediated rejection correlates with B-cell-dependent indirect antidonor alloresponses and autocrine regulation of interferon-gamma production by Th1 cells.
    Kidney Int. 2017;91:477-492.
    PubMed     Text format     Abstract available


    January 2017
  35. HAAS M, Mirocha J, Reinsmoen NL, Vo AA, et al
    Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.
    Kidney Int. 2017 Jan 16. pii: S0085-2538(16)30656.
    PubMed     Text format     Abstract available


    December 2016
  36. LOCKE JE, Reed RD, Massie A, MacLennan PA, et al
    Obesity increases the risk of end-stage renal disease among living kidney donors.
    Kidney Int. 2016 Dec 29. pii: S0085-2538(16)30613.
    PubMed     Text format     Abstract available


  37. LITJENS NH, Boer K, Zuijderwijk JM, Klepper M, et al
    Natural regulatory T cells from patients with end-stage renal disease can be used for large-scale generation of highly suppressive alloantigen-specific Tregs.
    Kidney Int. 2016 Dec 14. pii: S0085-2538(16)30599.
    PubMed     Text format     Abstract available


    October 2016
  38. CHERUKURI A, Salama AD, Carter CR, Landsittel D, et al
    Reduced human transitional B cell T1/T2 ratio is associated with subsequent deterioration in renal allograft function.
    Kidney Int. 2016 Oct 28. pii: S0085-2538(16)30481.
    PubMed     Text format     Abstract available


    August 2016
  39. BIENAIME F, Legendre C, Terzi F, Canaud G, et al
    Antiphospholipid syndrome and kidney disease.
    Kidney Int. 2016 Aug 20. pii: S0085-2538(16)30317.
    PubMed     Text format     Abstract available


    June 2016
  40. CHEN T, Cleland B, Nankivell BJ
    The Case | Rapidly progressing polyneuropathy in a dialysis patient.
    Kidney Int. 2016;89:1409-10.
    PubMed     Text format    


    May 2016
  41. DRAGUN D, Catar R, Philippe A
    Non-HLA antibodies against endothelial targets bridging allo- and autoimmunity.
    Kidney Int. 2016 May 14. pii: S0085-2538(16)30071.
    PubMed     Text format     Abstract available


  42. ROMANOWSKI K, Clark EG, Levin A, Cook VJ, et al
    Tuberculosis and chronic kidney disease: an emerging global syndemic.
    Kidney Int. 2016 May 10. pii: S0085-2538(16)30053.
    PubMed     Text format     Abstract available


  43. MA L, Langefeld CD, Comeau ME, Bonomo JA, et al
    APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease.
    Kidney Int. 2016 May 5. pii: S0085-2538(16)30012.
    PubMed     Text format     Abstract available


    April 2016
  44. ZHANG L, Lee G, Liu X, Pascoe EM, et al
    Long-term outcomes of end-stage kidney disease for patients with lupus nephritis.
    Kidney Int. 2016 Apr 8. pii: S0085-2538(16)00363.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Kidney Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: